Investor's Business Daily on MSN6h
Why IBD 50's Arcutis Is Outplaying The Biotech Tape And Just Reentered Its Buy Zone
Arcutis Biotherapeutics wants to eliminate a terrible trade-off for patients with eczema and psoriasis. And Arcutis stock investors are taking notice, sending shares sky-high over the past ...
32 years later, PC icon Myst finally feels complete thanks to a big new update
After remasters, remakes, and expansions, everything from the world of PC classic Myst is finally combined thanks to a great, ...